The Effect of Glomerular Filtration Rate and Troponin on the Prognosis of Patients with COVID-19

Öz

Aim: During the pandemic, clinicians have generally focused on treating respiratory tract infections. It determined that all organs are affected over time, especially the heart and kidneys, and the clinic deteriorates rapidly. We aimed to determine whether serial glomerular filtration rate and troponin tests would predict prognosis in patients with COVID-19. Material and Method: One hundred seven patients diagnosed with COVID-19 were included in this study. We evaluated in-hospital mortality based on the presence and absence of troponin elevation and renal dysfunction at patients’ first and last examinations. We also investigated the correlation of both troponin elevation and renal dysfunction with age, pneumonia severity, and each other. Results: Most surviving patients were female, and the average age was younger than the other group. The most common comorbidity was hypertension. It was observed that the patients with a high last glomerular filtration rate, low last troponin test, and low pneumonia severity survived. The most important factors affecting the prognosis were the severity of pneumonia and the last glomerular filtration rate. Conclusion: Based on the conclusion from this study, the prognosis of patients with rapidly worsening cardiac and renal function can deteriorate. Those tests require close monitoring.

Anahtar Kelimeler

• COVID-19
• glomerular filtration rate
• troponin
• pneumonia severity; prognosis

Kaynakça

1. 1. Connors JM, Levy JH. Thrombo inflammation and the hypercoagulability of COVID-19. J thromb Haemost. 2020;18(7):1559–61.
2. 2. Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Rep. 2021;11(1):1–9.
3. 3. Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, et al. A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 global pandemic. Am J Med Sci. 2020;360(1):5–34.
4. 4. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis. Am J Emerg Med. 2021;44:352–7.
5. 5. Izquierdo A, Mojón D, Bardají A, Carrasquer A, CalvoFernández A, Carreras-Mora J, et al. Myocardial injury as a prognostic factor in mid-and long-term follow-up of COVID-19 survivors. J Clin Med. 2021;10(24):5900.
6. 6. Hanson PJ, Liu-Fei F, Ng C, Minato TA, Lai C, Hossain AR, et al. Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort. Lab Invest. 2022;102(8):814–25.
7. 7. Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2021;17(2):81–2.
8. 8. Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–64.

9. 9. Uribarri A, Nunez-Gil IJ, Aparisi A, Becerra-Munoz VM, Feltes G, Trabattoni D, et al. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry. J Nephrol. 2020;33:737–45.
10. 10. Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):1–7.
11. 11. Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, et al. Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease. Kidney Int. 2019;96(2):429–35.
12. 12. Altun Y. Covid-19 pandemisinde kaygı durumu ve hijyen davranışları. Sürekli Tıp Eğitimi Derg. 2020;29(5):312–7.
13. 13. Carda R, Aceña Á, Pello A, Cristóbal C, Tarín N, Huelmos A, et al. The prognostic value of high-sensitive troponin-I in stable coronary artery disease depends on age and other clinical variables. Cardiology. 2015;132(1):1–8.
14. 14. Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380–3.
15. 15. Rangaswami J, Bhalla V, Blair JE, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840–e878.
16. 16. Apetrii M, Enache S, Siriopol D, Burlacu A, Kanbay A, Kanbay M, et al. A brand-new cardiorenal syndrome in the COVID-19 setting. Clin Kidney J. 2020;13(3):291–6.
17. 17. Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–64.
18. 18. Keleş DV, Karataş S, Güven O. Covid-19 and Bacterial Infections, 1st ed. Ed: Yücetaş SC. Health and Science-2. İstanbul: Efe Akademi; 2022. ss. 63–9.
19. 19. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–27.
20. 20. Tveito K. Cytokine storms in COVID-19 cases? Tidsskrift for Den norske legeforening;2020. [Accessed: 8.8.2022]. https://tidsskriftet.no/en/2020/03/redaksjonell-kommentar/ cytokine-storms-covid-19-cases
21. 21. Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. Acute myocarditis presenting as a reverse TakoTsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861–2.
22. 22. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019(COVID-19). JAMA Cardiol. 2020;5(7):811–8.
23. 23. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):80210. https://doi.org/10.1001/jamacardio.2020.0950
24. 24. Darmon M, Clec’h C, Adrie C, Argaud L, Allaouchiche B, Azoulay E, et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9(8):1347–53.
25. 25. T. C. Sağlık Bakanlığı [Internet]. COVID-19 bilgilendirme platformu; 2020. [Accessed: 24.7.2022]. https://covid19. saglik.gov.tr/TR-66341/antisitokin-antiinflamatuar-tedavilerkoagulopati-yonetimi.html
26. 26. Kalim S, Szczech LA, Wyatt CM. Acute kidney injury in HIVinfected patients. In: Seminars in Nephrology; 2008. Vol. 28, No. 6, pp. 556–62. WB Saunders.
27. 27. Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. Longterm clinical consequences of acute kidney injury in the HIVinfected. Kidney Int. 2010;78(5):478–85.
28. 28. Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis. 2021;77(2):204–15.
29. 29. Arslan K, Baş S. COVID-19 Hastalarında Hipertansiyon Sıklığı ve Hipertansiyonu Olan COVID-19 Hastalarında Klinik Seyir. MN Kardiyoloji. 2021;28(3):151–7.
30. 30. Keleş DV, Dönmez M, Güven O. Covid-19’un Akciğerler Üzerine Etkisi. In: Gülaçtı U, editör. COVID-19 ve Sağlık Araştırmaları-6, 1st ed. İstanbul: Efe Akademi; 2022. 7–16.